The diagnostic process for patients with suspected autoimmune diseases is often long and uncertain, characterized by vague symptoms, overlapping clinical presentations and limitations in traditional serological testing. This complexity can delay accurate diagnosis and treatment, leading to disease progression and diminished quality of life. This webinar will explore how advanced serological testing methods like AVISE CTD are helping clinicians navigate this complexity by enhancing diagnostic precision for autoimmune diseases, including lupus and rheumatoid arthritis.
AVISE® tests provide a comprehensive serological profile by combining cell-bound complement activation products (CB-CAPs), high-quality systemic lupus erythematosus (SLE)-specific biomarkers, and a proprietary algorithm to support more confident and earlier diagnosis, enabling physicians to act decisively at a critical juncture in the patient’s journey. Through real-world case studies, this session will highlight how diagnostic clarity from enhanced testing approaches has informed provider decision-making, enabled appropriate therapeutic initiation, and ultimately led to improved patient outcomes.
Tailored for rheumatologists and healthcare professionals involved in autoimmune diseases, this webinar offers practical, evidence-based insights into the role of innovative diagnostics in daily clinical practice. Attendees will gain a deeper understanding of how leveraging advanced diagnostic tools, like AVISE CTD can enhance decision-making and improve the lives of patients affected by these complex and chronic conditions.
Register now to discover how advanced serological testing is revolutionizing the diagnosis and treatment of autoimmune diseases.
Speakers

Dr. Alfred Kim, MD, PhD, Associate Professor, Medicine, Washington University School of Medicine
Dr. Alfred Kim is an Associate Professor of Medicine at Washington University School of Medicine, where he directs the Lupus Center, which he founded in 2013. He also directs the Biobanking and Phenotyping Core within the NIH/NIAMS P30-funded Rheumatic Diseases Research Resource-based Center, is a Faculty Scholar at the Institute of Public Health and serves as the Associate Program Director for the Rheumatology Fellowship Program, all at Washington University. Additionally, he is the Chief Medical Officer at Kypha, Inc., an innate immune diagnostics company.

Dr. Priya Reddy, MD, Rheumatologist
Dr. Priya Reddy is a practicing rheumatologist at AARA-Southwest Florida Rheumatology, based in Tampa Bay. Dr. Reddy completed a fellowship in rheumatology at the University of Washington in Seattle, Washington. Before opening Southwest Florida Rheumatology in 2010, she worked as an Assistant Professor in the Division of Rheumatology at the University of South Florida, and continues to teach and train Internal Medicine residents as Faculty and Curriculum Coordinator for Brandon Regional Hospital Residency Program- USF. She is the immediate past president of the Florida Society of Rheumatology (FSR), has served on the board of directors of the American Arthritis & Rheumatology Associates (AARA/Bendcare), and currently serves as Secretary/Treasurer for the Association of Women in Rheumatology (AWIR).

Dr. James Mossell, DO, FACR, Director of Rheumatology, Tift Regional Medical Center
Dr. James Mossell attended the New York College of Osteopathic Medicine and graduated in 1989. He completed his Internship at Sisters of Charity Hospital in Buffalo, NY in 1990 and completed 3 years of Internal Medicine Residency at SUNY Buffalo where he was Chief Medical Resident from 1992-1993. He was awarded the J. Fredrick Painton MD award for Excellence in Teaching upon graduation. He completed his Rheumatology Fellowship at the University of Florida in Gainesville ,FL and while there was a physician for the Shuttle Program at NASA. Dr. Mossell then moved to Tifton, GA in 1995 where he worked with Dr. John Sharpe for the first 3 years of practice. Dr. Mossell is actively involved in clinical research in Rheumatoid Arthritis, Lupus and Gout. He has been a lead author on several abstracts presented at ACR and presented an abstract pertaining to gout patients at EULAR in 2024 in Vienna, Austria.
Who Should Attend?
This webinar will appeal to:
- Rheumatologists/Rheumatology Nurse Practitioners/Rheumatology Physician Assistants
- Generalists
- Immunologists
- Healthcare professionals
- Clinical Researchers at hospitals and Specialist Consultants in Rheumatology and Clinical Immunology
- Program Leads/Heads of Rheumatology at pharma and biotech companies
What You Will Learn
Attendees will:
- Understand how advanced autoimmune testing supports diagnostic clarity in early or ambiguous clinical presentations
- Review case-based evidence of how serological test results can inform long-term clinical decisions
- Learn how providers are using comprehensive serologic profiles to increase confidence in diagnosis and inform individualized patient care
- Gain confidence in using innovative diagnostic tools along with routine autoimmune workups for better care
Xtalks Partner
Exagen Inc.
Exagen Inc. is a patient-focused and discovery-driven commercial-stage life sciences company. We aid patients and healthcare providers in the diagnosis, prognosis, and management of autoimmune conditions. Our relentless pursuit for laboratory excellence has enabled us to develop next-generation autoimmune testing to help empower physicians and improve patients’ lives.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account